{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:53:27Z","timestamp":1792036407643,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejca.2020.03.031","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:35:24Z","timestamp":1589740524000},"page":"33-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan H.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.03.031_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2020.03.031_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.ejca.2020.03.031_bib3","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.ejca.2020.03.031_bib4","unstructured":"Uterine Neoplasms. NCCN clinical practice guidelines in oncology. National Comprehensive Cancer Network. https:\/\/www.nccn.org\/professionals\/physician_gls\/. [Accessed 17 January 2020]."},{"key":"10.1016\/j.ejca.2020.03.031_bib5","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J Clin Oncol \u2013 Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet \u2013 Off Organ Int Feder Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2020.03.031_bib7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.bjc.6602035","article-title":"Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis","volume":"91","author":"Tebeu","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2020.03.031_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2020.03.031_bib9","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2019.30.e8","article-title":"A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma","volume":"30","author":"Takahashi","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2018.02.012","article-title":"Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer","volume":"149","author":"Matsuo","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib11","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3802\/jgo.2018.29.e34","article-title":"Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy","volume":"29","author":"Tate","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.601","article-title":"Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database","volume":"218","author":"Seagle","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2020.03.031_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.03.011","article-title":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","volume":"145","author":"Scott","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/IGC.0000000000000072","article-title":"Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature","volume":"24","author":"Shiozaki","year":"2014","journal-title":"Int J Gynecol Cancer \u2013 Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.ejca.2020.03.031_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3802\/jgo.2014.25.1.30","article-title":"FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype","volume":"25","author":"Haltia","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/AOG.0b013e3181a94568","article-title":"Stage IIIA endometrial carcinoma: outcome and predictors of survival","volume":"114","author":"Bansal","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2020.03.031_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10269-008-0898-z","article-title":"Positive peritoneal cytology and its prognostic value in endometrioid adenocancer confined to the uterus","volume":"10","author":"Metindir","year":"2008","journal-title":"Oncologie"},{"key":"10.1016\/j.ejca.2020.03.031_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2006.03.003","article-title":"Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?","volume":"103","author":"Saga","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2020.03.031_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2017.03.017","article-title":"Surgical-pathological findings in type 1 and 2 endometrial cancer: an NRG Oncology\/Gynecologic Oncology Group study on GOG-210 protocol","volume":"145","author":"Creasman","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib23","unstructured":"National Cancer Institute's. The surveillance, epidemiology, and end results (SEER) program. http:\/\/seer.cancer.gov\/. [Accessed 16 January 2020]."},{"key":"10.1016\/j.ejca.2020.03.031_bib24","unstructured":"National Cancer Registrars Association. http:\/\/www.ncra-usa.org\/i4a\/pages\/index.cfm?pageid"},{"key":"10.1016\/j.ejca.2020.03.031_bib25","unstructured":"National Death Index. Available online: https:\/\/www.cdc.gov\/nchs\/ndi\/. [Accessed on 28 June 2019]."},{"key":"10.1016\/j.ejca.2020.03.031_bib26","unstructured":"Corpus Carcinoma. CS site-specific factor 2 peritoneal cytology. http:\/\/web2.facs.org\/cstage0205\/corpuscarcinoma\/CorpusCarcinoma_kpo.html. [Accessed 18 January 2020]."},{"issue":"Suppl. 23","key":"10.1016\/j.ejca.2020.03.031_bib27","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1002\/cncr.29054","article-title":"Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2","volume":"120","author":"Jamison","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.03.031_bib28","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.ejca.2020.03.031_bib29","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.18632\/oncotarget.25550","article-title":"Trends and outcomes of women with synchronous endometrial and ovarian cancer","volume":"9","author":"Matsuo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.03.031_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","article-title":"Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation","volume":"124","author":"Voss","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/AOG.0000000000000636","article-title":"Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome","volume":"125","author":"Matsuo","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2020.03.031_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2020.03.031_bib33","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2020.03.031_bib34","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2012.41.6701","article-title":"Comparative effectiveness research in oncology methodology: observational data","volume":"30","author":"Hershman","year":"2012","journal-title":"J Clin Oncol \u2013 Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib35","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ejca.2020.03.031_bib36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2020.03.031_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jso.24049","article-title":"Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer","volume":"112","author":"Matsuo","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib38","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol \u2013 Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.03.031_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv158","article-title":"Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG oncology\/gynecologic oncology group 210 trial","volume":"107","author":"Felix","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2020.03.031_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/IGC.0b013e3181ca2290","article-title":"Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis","volume":"20","author":"Polyzos","year":"2010","journal-title":"Int J Gynecol Cancer \u2013 Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.ejca.2020.03.031_bib42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2011.07.1146","article-title":"Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis","volume":"96","author":"Chang","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejca.2020.03.031_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PAS.0000000000000754","article-title":"The microcystic, elongated, and fragmented (MELF) pattern of invasion: a single institution report of 464 consecutive FIGO grade 1 endometrial endometrioid adenocarcinomas","volume":"41","author":"Joehlin-Price","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2020.03.031_bib44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.03.031_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijc.32872","article-title":"Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study","volume":"147","author":"Mayo-de-Las-Casas","year":"2020","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920302112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920302112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:26:34Z","timestamp":1760732794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920302112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":45,"alternative-id":["S0959804920302112"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.031","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}